MED vs QDEL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

MED

47.5
AI Score
VS
MED Wins

QDEL

37.3
AI Score

Investment Advisor Scores

MED

48score
Recommendation
HOLD

QDEL

37score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric MED QDEL Winner
Forward P/E 12.4844 7.2254 QDEL
PEG Ratio 0.972 2.0638 MED
Revenue Growth -27.6% 2.8% QDEL
Earnings Growth -87.2% -77.1% QDEL
Tradestie Score 47.5/100 37.3/100 MED
Profit Margin -8.1% -39.2% MED
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL MED

Relative Price Performance (Last 90 Days)

MED 1M: +3.9% · 3M: +1.0% QDEL 1M: -20.6% · 3M: -16.4%

Current Technical Phase

MED

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.4% over 20 days), RSI 53

RSI (14): 52.8 · Price: $12.04

QDEL

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.8%), weak momentum, RSI 31

RSI (14): 31.0 · Price: $11.78

Fundamentals Snapshot

Metric MED QDEL
Market Cap
Forward P/E -43.0 8.2
Trailing P/E
Revenue (TTM)
Revenue Growth -0.3% 0.0%
Gross Margin 0.7% 0.4%
Operating Margin -0.1% 0.0%
EPS -2.31 -14.84
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MED is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.